Nuvation Bio Inc.

US$4.16As of Sun 8 Nov 2026, 12:00 UTC
NYSE:NUVBHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (13.22%)
Div yield —
ROE (49.09%)
Biotechnology
Beta (5Y) 1.73
PE TTM —
TSR TTM (20.31%)
Mkt cap US$1.469B
ROIC (12.54%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.38
5.18%
38.61%
Hold 11|11|2|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
25.85%
26.57%
14.11%
2.16%
Revenue$M
87.42
90.15
89.60
92.63
3.00%
8.54%
7.87%
6.11%
Peers (US$1.469B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.201
0.594
0.510
EBIT/Intx
1.896
0.240
0.232
Own earn%
(8.05)
(15.59)
(19.30)
Sh yield%
39.82
18.60
18.44
Owners
Insiders/Inst%
1.25
69.06
Short interest%
0.81
SBC / revenue%
2.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
25–34
$1 testx
—
Incr. ROIC%
6